Metabolism of Red Blood Cells in Chronic Renal Failure
Clicks: 279
ID: 272405
1979
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.3
/100
279 views
34 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #4 of 6 articles by views in nephron
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
This paper starts a series on red blood cell (RBC) metabolism in patients with chronic renal failure (CRF). The glycolytic enzyme levels and in vitro half-lives of these patients’ RBCs were determined. A number of enzymes (hexokinase, glucose-6-phosphate isomerase, fructose-6-phosphate kinase, aldolase, glyceraldehyde-3-phosphate dehydrogenase and lactate dehydrogenase) showed higher activities than in normal control RBCs. Other enzyme activities were normal. These results were discussed and several possible mechanisms considered. We favour the point of view of a shortened life span of the RBCs in CRF, making the most unstable enzymes of the glycolytic sequence appear increased as compared with normal controls.
| Reference Key |
battaner1979nephronmetabolism
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | J.L. Rodríguez-Commes,J.M. Tabernero,P. Martin-Vasallo,S. DeCastro,E. Battaner;J.L. Rodríguez-Commes;J.M. Tabernero;P. Martin-Vasallo;S. DeCastro;E. Battaner; |
| Journal | nephron |
| Year | 1979 |
| DOI |
10.1159/000181677
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.